Short Interest in Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Expands By 386.5%

Carl Zeiss Meditec AG (OTCMKTS:CZMWYGet Free Report) was the recipient of a significant increase in short interest in July. As of July 31st, there was short interest totaling 180 shares, an increase of 386.5% from the July 15th total of 37 shares. Based on an average daily volume of 2,823 shares, the short-interest ratio is currently 0.1 days.

Carl Zeiss Meditec Price Performance

OTCMKTS CZMWY opened at $35.82 on Wednesday. The stock’s fifty day moving average price is $32.08 and its 200 day moving average price is $31.08. Carl Zeiss Meditec has a 1 year low of $26.65 and a 1 year high of $55.94.

Analysts Set New Price Targets

A number of brokerages recently weighed in on CZMWY. Zacks Research upgraded Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. UBS Group lowered shares of Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research report on Tuesday. One investment analyst has rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Check Out Our Latest Stock Analysis on CZMWY

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.

Further Reading

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.